Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Esperion Therapeutics
ESPR
$573M
| $2.97M | ﹤0.01% |
57,900
+10,200
| +21% | +$523K |
|
1477
O-I Glass
OI
$1.99B
| $2.97M | ﹤0.01% |
330,624
+28,800
| +10% | +$259K |
|
1478
EchoStar
SATS
$21.5B
| $2.97M | ﹤0.01% |
106,200
+9,400
| +10% | +$263K |
|
1479
Kulicke & Soffa
KLIC
$2.01B
| $2.97M | ﹤0.01% |
142,500
+20,300
| +17% | +$423K |
|
|
PTLA
1480
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.97M | ﹤0.01% |
164,957
+21,600
| +15% | +$389K |
|
1481
Terex
TEX
$3.46B
| $2.96M | ﹤0.01% |
157,800
+19,500
| +14% | +$366K |
|
1482
Sturm, Ruger & Co
RGR
$600M
| $2.96M | ﹤0.01% |
38,900
+5,000
| +15% | +$380K |
|
1483
NMI Holdings
NMIH
$3.08B
| $2.95M | ﹤0.01% |
183,574
+51,700
| +39% | +$831K |
|
|
ROIC
1484
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $2.95M | ﹤0.01% |
260,000
+35,000
| +16% | +$397K |
|
1485
McGrath RentCorp
MGRC
$3.01B
| $2.93M | ﹤0.01% |
54,300
+7,200
| +15% | +$389K |
|
|
GLUU
1486
DELISTED
Glu Mobile Inc.
GLUU
| $2.93M | ﹤0.01% |
316,000
+89,800
| +40% | +$832K |
|
1487
Stitch Fix
SFIX
$714M
| $2.93M | ﹤0.01% |
117,300
+15,800
| +16% | +$394K |
|
1488
Verra Mobility
VRRM
$3.92B
| $2.92M | ﹤0.01% |
284,200
+83,600
| +42% | +$860K |
|
|
KRTX
1489
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.92M | ﹤0.01% |
+26,200
| New | +$2.92M |
|
1490
Acushnet Holdings
GOLF
$4.38B
| $2.92M | ﹤0.01% |
83,900
+18,300
| +28% | +$637K |
|
1491
BILL Holdings
BILL
$5.19B
| $2.91M | ﹤0.01% |
+32,300
| New | +$2.91M |
|
1492
Aurinia Pharmaceuticals
AUPH
$1.68B
| $2.91M | ﹤0.01% |
180,600
+23,200
| +15% | +$374K |
|
|
MINI
1493
DELISTED
Mobile Mini Inc
MINI
| $2.91M | ﹤0.01% |
98,500
+13,000
| +15% | +$384K |
|
1494
Atkore
ATKR
$2.06B
| $2.91M | ﹤0.01% |
106,200
+15,100
| +17% | +$413K |
|
1495
HNI Corp
HNI
$2.07B
| $2.9M | ﹤0.01% |
94,900
+11,800
| +14% | +$361K |
|
1496
MacroGenics
MGNX
$100M
| $2.9M | ﹤0.01% |
103,900
+13,800
| +15% | +$385K |
|
1497
OSI Systems
OSIS
$3.95B
| $2.9M | ﹤0.01% |
38,800
+5,000
| +15% | +$373K |
|
1498
Pricesmart
PSMT
$3.52B
| $2.88M | ﹤0.01% |
47,800
+3,400
| +8% | +$205K |
|
1499
Dycom Industries
DY
$7.47B
| $2.88M | ﹤0.01% |
70,400
+9,300
| +15% | +$380K |
|
1500
Sonos
SONO
$1.83B
| $2.87M | ﹤0.01% |
196,400
+154,300
| +367% | +$2.26M |
|